Examining the pros and cons of semaglutide A new study finds lowered risk of 42 health outcomes and increased risk of 19 for people using GLP-1RAs, highlighting the ‘far-reaching potential’ of the drugs.
GLP-1 receptor agonists linked to kidney failure prevention: Study It found the diabetes and weight-loss drugs can reduce deterioration regardless of diabetes status, but supply remains an issue.
Lack of safety data prompts guidance on oestrogen therapy A summary of evidence is out for prescribing oestrogen treatments for the estimated 75% of breast cancer patients who develop genitourinary symptoms.
RACGP opposes GLP-1 RA prescribing restrictions Changing the authority type for initiating the diabetes medication will make it difficult for ‘already burdened’ GPs to negotiate, the PBS has been told.
New breast cancer research has ‘immediate implications’ The study has produced fresh evidence about the use of androgens as a potential treatment for oestrogen receptor-positive breast cancer.
Popular hypertension drug linked with suicide Angiotensin receptor blockers may be associated with a higher risk of suicide than alternative medications, a new study has found.
Old doc, new disease: Anti-NMDA receptor encephalitis Dr Casey Parker reflects on an intriguing presentation that made him ask: What else do I not know?